That a decision is replicable refers to the fact that it is possible for others to make an informed judgement on the likelihood of a particular outcome, in the light of the relevant legal materials, the canons of reasoning used in a system, and an acquaintance with the general culture from which the decision-makers are drawn.
In this study, we investigated the prognostic value of BAALC expression levels on clinical outcome in the light of other currently relevant molecular prognosticators.
Future studies are necessary to examine the propensity for different negative symptoms to co-occur in individual patients and the extent to which different clusters of symptoms are associated with clinical outcomes, particularly in the light of previous research which suggests that negative symptoms segregate into two subdomains relating to amotivation and reduced emotional expression.
The challenge, but also an additional opportunity, ahead is the appraisal of heterogeneity across outcome measures in the light of the complementary qualitative data.
In the following, we will focus on measuring the impact of an intervention accurately in the context of pharmacy claims databases and give specific consideration to our outcome measures in the light of the issues raised by Maclure et al. (2006) in their review of measuring prescription-related improvements in the primary care setting [ 39].
In accordance with the effectiveness of instructional materials in the long run, it is important to synthesize the outcomes of this study in the light of pedagogical implications.
This paper addresses group differences in labor market outcomes in Mexico under the light of the wealth of literature for the USA.
Lastly, this paper discusses about the outcomes of the proposed approach in the light of both the theory and practical.
Public discourse tends to focus on the IT programme's troubled history, whereas the greater need is to debate the desired outcome of electronic health records in the light of the identified policy tensions and programme changes.
The outcomes of these trials can be interpreted in the light of the inverted U-shaped dose-effect curve (IUSDEC) pharmacodynamic properties typical of some pharmacologically active substances, most notably D2-receptor antagonists [53].
